This major reference work is the most comprehensive resource on oncologic critical care. The text reviews all significant aspects of oncologic ICU practices, with a particular focus on challenges encountered in the diagnosis and management of the critically ill cancer patient population. Comprised of over 140 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care.
Written by worldwide experts in the field, Oncologic Critical Care is a valuable resource for intensivists, advance practice providers, nurses, and other healthcare providers, that will help close significant knowledge and educational gaps within the realm of medical care for critically ill cancer patients.
Auflage
Sprache
Verlagsort
Verlagsgruppe
Springer International Publishing
Zielgruppe
Illustrationen
145
80 s/w Abbildungen, 130 farbige Tabellen, 145 farbige Abbildungen
XLV, 2099 p. 225 illus., 145 illus. in color. Print + eReference.
Maße
Höhe: 23.5 cm
Breite: 15.5 cm
ISBN-13
978-3-319-74589-3 (9783319745893)
DOI
10.1007/978-3-319-74588-6
Schweitzer Klassifikation
Dr. Joseph L. Nates is a Professor at the University of Texas MD Anderson Cancer Center. He has lived and practiced medicine in several countries. Currently, he is the Deputy Chair of the Department of Critical Care in the Division of Anesthesiology, Critical Care, and Pain Medicine. Dr. Nates is also the Medical Director of the 70-bed Oncologic Surgical and Medical Intensive Care Units and the Founder and President of the Oncologic Critical Care Research Network (ONCCC-R-NET), a global organization dedicated to the advancement of oncologic critical care research and education. Through his organization, Dr. Nates has been leading the pioneering efforts to establish Oncologic Critical Care as a new subspecialty and disseminate this knowledge worldwide. As the foundation for this objective, he has led and coauthored the first two comprehensive oncologic critical care textbooks, in both Spanish and English languages. He has also established regional and global collaborative networks and organized several Oncologic Critical Care symposiums.
Throughout his career, Dr. Nates has occupied multiple leadership positions and received numerous awards, among them the Presidential Award for "Outstanding Achievement and Leadership for Elimination of Ventilator-Associated Pneumonia" from the Department of Health and Human Services and the four leading Critical Care Societies in the USA in 2012, the "Bill Aston Award for Quality" from the Texas Hospital Association, and Distinguished Service Award in 2015, as well as many other research awards during his career. In 2018, for his contributions to critical care, the American College of Critical Care Medicine awarded him the title
Master of Critical Care Medicine. The same year, for his international contributions to the development of
Oncologic Critical Care, the Chilean Society of Critical Care and Emergency Medicine awarded him the title
International Master of Critical Care Medicine.
Dr. Kristen J. Price was born and raised in New Orleans, Louisiana. She received her undergraduate degree in Marine Science from the University of Tampa followed by a Doctor of Medicine degree from Louisiana State University Medical Center in New Orleans. She completed an Internal Medicine residency, Chief Medical Residency, and Pulmonary and Critical Care fellowship at the University of Texas Health in Houston. Following training, she joined the faculty at the University of Texas MD Anderson Cancer Center and currently holds the title of Professor and Chair, Department of Critical Care and Respiratory Care. Under her leadership, the number of faculty and advance practice providers has grown substantially. She also oversees the Respiratory Care Department and the Section of Integrated Bioethics in Cancer Care. Dr. Price developed the multifaceted "Intensive Care Unit Organizational Infrastructure" to systematically organize, establish, and sustain evidence-based clinical, educational, and research initiatives in the ICU. Her main focus of research has been in the outcomes of critically ill oncology patients, particularly those with hematologic malignancies and respiratory failure. She is an active member of the Society of Critical Care Medicine and currently serves on the "Academic Leaders in Critical Care Medicine" task force. Dr. Price has four grown children and currently resides in Houston, Texas.
Part 1. Organization and Management of an Oncologic Critical Care Unit
1. Oncologic Critical Care Department Organization 2. Critical Care Staffing 3. ICU Admission and Discharge Criteria 4. Quality Assurance and Improvement 5. ICU Utilization 6. Current Trends in ICU Beds, Use, Occupancy, and Costs in the United States 7. Early Warning Systems for the ICU8. Patient Risk Prediction Model (Severity of Illness Scores)
Part 2. Multidisciplinary Care
9. Rapid Response Team 10. Nursing11. Pharmacy 12. Nutrition 13. Physical and Occupational Therapy14. Patient Support15. Advocacy and Social Work16. Chaplaincy
Part 3. Advance Practice Providers
17. Role of the APPs in the Onco-ICU18. Credentialing19. Competencies
Part 4. Clinical Pharmacy
20. Chemotherapy 21. Considerations for Medications Commonly Utilized in the Oncology Population22. Supportive Care Considerations
Part 5. Dermatologic Complications 23. GHVD, TEN, and Mycosis Fungoides
Part 6. Neurologic Diseases
24. Medication-induced Neurotoxicity 25. Delirium and Psychosis 26. Seizures and Status Epilepticus 27. Stroke 28. Increased Intracranial Pressure (brain mets, ich, hydrocephalus, etc) 29. Posterior Reversible Encephalopathy Syndrome (PRES) 30. Tumor-related Diseases/Neoplastic Meningitis/Leptomeningeal Disease 31. Frequent CNS Infections in the Immunosuppressed Patient 32. Intracranial Hemorrhage Focused on Cancer and Hemato-oncologic Patients33. Spinal Cord Compression 34. TCD in the ICU
Part 7. Respiratory Diseases
35. Acute and Chronic Respiratory Failure 36. Oxygen therapy (low-flow and high-flow oxygen therapy) 37. Respiratory Care of the Critically Ill Patient 38. Management of Tracheobronchial Diseases 39. Pulmonary Hypertension 40. ARDS and the differential diagnosis of pulmonary infiltrates in the cancer patient41. Diffuse Alveolar Hemorrhage 42. Differentiation (Retinoic acid ATRA) Syndrome 43. Late Non Infectious Pulmonary Complications in Hematopoietic Stem Cell Transplantation 44. Treatment-related Lung Injury 45. Pneumonia in the Cancer Patient 46. Ventilatory Strategies and Weaning from Mechanical Ventilation 47. Noninvasive Ventilation 48. High Frequency Ventilation 49. Prone Ventilatory Therapy 50. Bi-Level and Airway Pressure Release Ventilation 51. NAVA 52. ECMO in Cancer Patients 53. Tracheostomy: Appropriateness and Indications in Cancer Patients 54. Pleural Disease, Malignant and Benign Pleural Effusions55. Sleep Disorders in the Oncologic ICU
Part 8. Cardiovascular Diseases
56. Hemodynamic evaluation57. Acute Coronary Syndrome Thrombocytopenia and Antiplatelet Therapy in the Cancer Patient 58. Interventional Cardiology in the Cancer Patient 59. Arrhythmias in the Cancer Patient 60. Management of Pericardial Effusions/Tamponade 61. Chemotherapy-related Cardiovascular Complications 62. Cardiopulmonary Resuscitation in the Cancer Patient
Part 9. Gastrointestinal Disease
63. Gastrointestinal Bleeding 64. Malignant Ascites 65. Hepatobiliary Disease66. Acute abdomen in the cancer patient
Part 10. Genitourinary Disease
67. Hematuria68. Hemorrhagic cystitis69. Obstructive Uropathy in the Cancer Patient
Part 11. Renal Disease
70. Acute Renal Failure71. Renal Replacement Therapy
Part 12. Metabolic/Endocrine Complications
72. Adrenal Emergencies 73. Carcinoid Crises 74. Thyroid Emergencies 75. Electrolytic Abnormalities 76. Hypoglycemia and Hyperglycemia in the Cancer Patient
Part 13. Hematologic Diseases
77. Malignant Hematological Diseases78. Benign Hematological Diseases 79. Immunology and molecular biology for the intensivist
Part 14. Transfusion Medicine
80. Statistics 81. Blood Products 82. Transfusion Reactions 83. Transfusion Related Lung Injury 84. Alternatives to Blood Products85. Massive Bleeding Protocol 86. Transfusion Thresholds
Part 15. Vascular Complications
87. Management of Arterial Bleeding 88. Prevention and Management of Venous Thromboembolism in the Cancer Patient 89. SVC Syndrome 90. Catheter-related Deep Vein Thrombosis
Part 16. Infectious Diseases
91. Infection Control Procedures 92. Neutropenic Fever 93. Sepsis and Management of Septic Shock 94. Management of Multi-Drug Resistant Organisms 95. Fungal Infections 96. Viral Infections 97. Bacterial and Atypical Infections 98. Catheter and Device Related Infections 99. Nosocomial Infections and Ventilator Associated Pneumonia 100. Protozoal Infections in the Cancer Patients101. Antibiotic Stewardship 102. Tropical diseases in the cancer patient103. Soft tissue infections
Part 17. Post-Surgical Care of the Critically Ill Cancer Patient
104. Neurosurgery105. Head & Neck Surgery 106. Plastic Surgery & Flap Graft Management 107. Thoracic Surgery 108. GI Surgery 109. Hepatic Surgery 110. Pancreatic Surgery 111. Genitourinary Surgery 112. Orthopedic Surgery 113. Interventional Radiology 114. Radiation Therapy & Gamma Knife Procedures 115. MRI 116. Outpatient Surgery
Part 18. Special Patient Populations
117. Management of the Pregnant Critically Ill Cancer Patient 118. Special Considerations of Hemato-Oncologic Critically Ill Patient 119. Pediatric Cancer Critical Care
Part 19. Critical Care Procedures
120. ICU Procedures by APP 121. Management of the Airway in the Cancer Patient 122. Use of Ultrasound Guidance 123. Interventional Radiology Procedures
Part 20. Ethics
124. Do Not Resuscitate Orders125. Ethics Consultation126. End of Life Care127. Medical Futility
Part 21. Pain Management, Palliative Care, and Outcomes
128. Acute Pain 129. Chronic Pain 130. Substance Withdrawal 131. Palliative Care in the critically ill cancer patient 132. Outcomes in Critically Ill Oncologic Patients
